Simplex Trading, LLC Xenon Pharmaceuticals Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$36.25 - $43.75 $50,315 - $60,725	-1,388 Reduced 34.9%	2,589 $100,000
Q1 2024 Apr 25, 2024	SELL	$42.66 - $50.04 $1.04 Million - $1.22 Million	-24,410 Reduced 85.99%	3,977 $171,000
Q4 2023 Feb 02, 2024	BUY	$28.7 - $46.46 $506,612 - $820,111	17,652 Added 164.43%	28,387 $1.31 Million
Q3 2023 Nov 01, 2023	BUY	$34.16 - $39.73 $366,707 - $426,501	10,735 New	10,735 $366,000
Q3 2022 Nov 04, 2022	SELL	$30.79 - $39.82 $15,641 - $20,228	-508 Reduced 54.04%	432 $15,000
Q2 2022 Aug 03, 2022	SELL	$25.44 - $35.16 $754,728 - $1.04 Million	-29,667 Reduced 96.93%	940 $28,000
Q3 2021 Oct 28, 2021	BUY	$14.86 - $19.45 $5,944 - $7,780	400 Added 1.32%	30,607 $566,000
Q2 2021 Aug 12, 2021	BUY	$16.81 - $20.0 $169,192 - $201,300	10,065 Added 49.97%	30,207 $562,000
Q1 2021 Apr 26, 2021	BUY	$13.65 - $21.31 $274,938 - $429,226	20,142 New	20,142 $360,000
Q3 2020 Oct 14, 2020	SELL	$10.82 - $13.35 $1,363 - $1,682	-126 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$10.21 - $14.9 $1,286 - $1,877	126 New	126 $1,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.